NEW YORK ( TheStreet) -- NuVasive (Nasdaq: NUVA) hit a new 52-week low Monday as it is currently trading at $13.52, below its previous 52-week low of $13.54 with 64,883 shares traded as of 9:55 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.

NuVasive has a market cap of $599.4 million and is part of the health care sector and health services industry. Shares are down 45.5% year to date as of the close of trading on Friday.

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Its products are used in applications for spine fusion surgery.

TheStreet Ratings rates NuVasive as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full NuVasive Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

If you liked this article you might like

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Masimo's Stock Is a Great Buy Right Now

NXPI, AAPL, C: Jim Cramer's Views

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook